Cytokinetics, Inc. (CYTK)
62.86
-1.09
(-1.70%)
USD |
NASDAQ |
Oct 21, 16:00
62.89
+0.03
(+0.05%)
After-Hours: 20:00
Cytokinetics Net Income (Annual) : -784.96M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -784.96M |
| December 31, 2024 | -589.53M |
| December 31, 2023 | -526.24M |
| December 31, 2022 | -388.96M |
| December 31, 2021 | -215.31M |
| December 31, 2020 | -127.29M |
| December 31, 2019 | -121.69M |
| December 31, 2018 | -106.29M |
| December 31, 2017 | -127.79M |
| December 31, 2016 | 16.45M |
| December 31, 2015 | -37.50M |
| December 31, 2014 | -14.65M |
| December 31, 2013 | -33.72M |
| Date | Value |
|---|---|
| December 31, 2012 | -40.37M |
| December 31, 2011 | -47.86M |
| December 31, 2010 | -49.29M |
| December 31, 2009 | 24.54M |
| December 31, 2008 | -56.37M |
| December 31, 2007 | -48.89M |
| December 31, 2006 | -57.12M |
| December 31, 2005 | -42.25M |
| December 31, 2004 | -37.20M |
| December 31, 2003 | -32.68M |
| December 31, 2002 | -23.08M |
| December 31, 2001 | -15.87M |
| December 31, 2000 | -13.08M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Bristol Myers Squibb Co. | 7.056B |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| BioMarin Pharmaceutical, Inc. | 348.90M |
| Exelixis, Inc. | 782.57M |
| Ionis Pharmaceuticals, Inc. | -381.39M |